Switzerland’s Otto Hofstetter is expanding its range of specialty injection moulds. In addition to its core expertise in PAC and PET, this family-owned company is now engineering and manufacturing moulds for the pharmaceutical and medtech industries. Injection mould expert Urs Harder leads the firm’s entry into this specialist field.
Shutterstock
As an international mould maker, the Swiss company has designed and implemented projects for many well-known companies in recent years. To fine-tune its services, processes and quality assurance uncompromisingly to the specific characteristics and requirements of this area of application, the company has now launched its MED business division.
“For almost 70 years, packaging producers around the world have valued our moulds for their precision, ease of maintenance and durability, as have PET preform producers for nearly 50 years," says CEO and owner Otto Hofstetter. With its decades of expertise, including numerous projects in the medical sector, he considers this expansion step as only logical.
Otto Hofstetter MED will manufacture injection moulds for primary pharmaceutical packaging, as well as medical and diagnostic products and packaging for food supplements. As it does in the PET and PAC sectors, the company offers a full line of services for its new MED range — from production advice and planning to engineering solutions and state-of-the-art quality control.
The Swiss mouldmakers offers guarantees for its pharmaceutical and medtech moulds as well as comprehensive on-site services and support.